Effects of ICAM-1 antisense oligonucleotide on the renal tubumolecule fibrinogen, and the matrix factor hyaluronan lointerstitium in mice with unilateral ureteral obstruction.
ICAM-1 expresses at basal or low levels on the surface sion in mouse kidney.
of glomerular mesangial cells and renal tubular epithelial Because antisense oligonucleotides (ASONs) provide a novel strategy to inhibit RNA transcription and thereby the synthesis of the protein, ASONs as therapeutic agents The intercellular adhesion molecule-1 (ICAM-1) is a have been developed during the past years. Recently, transmembrane glycoprotein that belongs to the Ig superASONs that inhibit the expression of ICAM-1 on either gene family. Its ligands are the membrane-bound integhuman or murine endothelial cells were identified [14, 15] . rin receptor lymphocyte function-associated antigen-1
The murine-specific ASON was shown to selectively in-(LFA-1) and Mac-1 on leukocytes, CD43, the soluble hibit the expression of ICAM-1 and infiltration of leukocytes in lesions of a colitis model or a transplantation model in a sequence-specific manner [16, 17] .
the ICAM-1 expression of the cultured renal TECs in vitro, the distribution of ICAM-1 ASONs in the kidney after intravenous injection, and the therapeutic effects controls for immunostaining consisted of equivalent concentration of an irrelevant murine monoclonal antibody of ICAM-1 ASONs on the renal injury of UUO mice. and the cells without stimulation of IL-1␤.
METHODS

Distribution of oligonucleotide in mouse in vivo Oligonucleotides synthesis
Studies were performed in female NIH mice (mean weight 31 Ϯ 3.6 g) purchased from the animal center Phosphorothioate oligonucleotides were synthesized by Cybersyn Inc. (Lenni, PA, USA). The sequences of of the Chinese PLA General Hospital. FITC-labeled oligonucleotides were given to the mice by intravenous the oligonucleotides used in this study have been previously described [16] : mouse ICAM-1 ASON, 5Ј-TGCA injection via the tail vein at the dose of 10 mg/kg. The mice were sacrificed at 24 hours after injection of the TCCCCCAGGCCACCAT-3Ј, and control oligonucleotide, 5Ј-TCGCATCGACCCGCCCACTA-3Ј. The conoligonucleotides. Kidney, liver, lung, and spleen were frozen in liquid nitrogen, and cryosections were pretrol oligonucleotide has the same base composition as the ICAM-1 anitsense oligonucleotide but in a different pared. The distribution of FITC-labeled oligonucleotide in the tissues was determined under a fluorescent microsequence. All of the oligonucleotides were purified by reverse-phase high-performance liquid chromatography scope (Nikon, Tokyo, Japan). (HPLC). For some studies, parts of oligonucleotides Induction of unilateral ureteral obstruction were labeled with fluorescein isothiocyanate (FITC) at the 5Ј-amine.
Female NIH mice were anesthetized and underwent left proximal ureteral ligation via a midline abdominal Primary culture of mouse renal tubular epithelial cells incision. After the UUO surgery, the mice were divided into three groups. Group A was treated with ICAM-1 Primary mouse renal TECs were generated following the method described by Wuthrich et al [18] . Briefly, ASON, which was injected intravenously at the dosage of 1 mg/kg/day every other day for one week. Group B single cortical tubular cell suspensions of freshly dissected kidney cortices from normal NIH mice were prepared by was treated with the control oligonucleotide in the same way, and group C was injected with normal saline solucollagenase dispersion, sequential sieving through steel meshes, and washing in RPMI 1640 medium (GIBCO tion only as a blank control. All of the mice were sacrificed at the seventh day. The weights of the whole body, BRL, Grand Island, NY, USA). TECs were grown to subconfluence on gelatin-coated flasks for six days in liver, spleen, and kidney were recorded, and blood samples were obtained for measurement of blood urea nitro-RPMI 1640 medium supplemented with 10% fetal calf serum (FCS; GIBCO BRL). The primary TECs were gen (BUN), serum creatinine (Cr), and glutamic pyruvic transaminase (GPT). The expression of ICAM-1 protein digested by 0.2% pepsin/ethylenediaminetetraacetic acid buffer (EDTA; GIBCO BRL) and planted to another and the number of Mac-1-positive cells were measured by immunohistochemical staining. The pathological flask for growing. The identified secondary TECs were used in the following experiments.
changes of the obstructed kidney were analyzed by a computer imaging system. The total RNA of renal tissue Oligonucleotides treatment of tubular epithelial cells was extracted for analysis of the ICAM-1 mRNA by Northern blotting. The cell transfection reagent DOTAP was purchased from Boehringer Mannheim (Mannheim, Germany). For
Immunohistological study of ICAM-1 and Mac-1 TEC transfection, oligonucleotides were sterilized by expressions in UUO mice centrifugation through 0.2 m centrex cellulose acetate filters and diluted to a concentration of 0.1 g/L in
Renal samples from the obstructed kidney of the UUO mice were frozen in OCT embedding medium (Miles 20 mmol/L HEPES buffer (pH 7.4). In this study, the DOTAP/oligonucleotides mixture was prepared at the Inc., IN, USA). Four micrometer cryosections were incubated with 5 g/mL of rat antimouse ICAM-1 monoratio of 1 g oligonucleotide per 1 L DOTAP. Transfected TECs were incubated for an additional four hours clonal antibody YN1/1.7.4, with 15 g/mL of Mac-1 antibody (Pharmingen, San Diego, CA, USA). The slides at 37ЊC and were then incubated with or without interleukin-1␤ (IL-1␤; 10 /mL) for 16 hours.
were incubated with horseradish peroxidase-labeled rabbit antirat IgG, which was developed and examined under Intercellular adhesion molecule-1 assay of tubular light microscope. epithelial cells Quantitative analysis of renal pathology in the The ICAM-1 expression on the TEC surface was deterobstructed kidney mined by immunocytochemical staining. ICAM-1 monoclonal antibody YN1/1,7,4 (1 g/mL) was a gift from Dr.
The 2 m paraffin sections from obstructed kidneys of the UUO mice were stained with periodic acid-Schiff Matsuda (Juntendo University, Tokyo, Japan). Negative It has been demonstrated that ICAM-1 expression inflammatory cells were counted using an eyepiece gratiof cultured epithelial cells surface was increased after cule (Olympus, Tokyo, Japan) at a magnification of ϫ400 stimulation of IL-1␤ [8, 20] . In our study, the results and were quantitated as cells per unit area (0.0625 mm 2 ) showed that ICAM-1 expression of TECs, which was of the tubulointerstitium. All of these data were extransfected with 100 or 200 nmol/L ICAM-1 ASON pressed as the mean values of 5 to 10 fields of the tubuthrough liposome-DOTAP, was significantly decreased lointerstitium in each section.
compared with that of TECs transfected with control Isolation of RNA of tubular epithelial cells and oligonucleotide (Fig. 1 ). The control oligonucleotide had kidney tissue no effect on the ICAM-1 expression of TECs compared with the blank control of transfection buffer. The results Total cellular RNA was isolated from confluent monoalso indicated that there was no inhibition of ICAM-1 layers of transfected TECs using TRIZOL reagent expression on TECs if the transfection of ICAM-1 (GIBCO BRL). The kidney cortex tissue was minced and ASON was performed without DOTAP. We compared homogenized in 5.5 mol/L guanidinium isothiocyanate the effects of ICAM-1 ASON transfection with or withcitrate buffer, and the total tissue RNA was isolated by out DOTAP. We found that the uptake of ICAM-1 a cesium chloride gradient centrifugation. The total RNA ASON by cultured TECs was significantly increased was quantitated with ultraviolet spectrophotometry.
when transfected with DOTAP (75.2 Ϯ 8.3% vs. 16.6 Ϯ RT-PCR and preparation of the mouse ICAM-1 4.8%). Northern blot analysis showed that total cellular cDNA probe mRNA levels of ICAM-1 from TECs transfected with The ICAM-1 primers were designed from the se-ICAM-1 ASON were significantly decreased compared quence of the mouse gene [19] : 5Ј-CAACTGGAAGCT with that of the control sample. Representative autora-GTTTGAGCTG-3Ј (sense) and 5Ј-GTGTTCACAGT diograms for ICAM-1 mRNA expression are shown in CTTGC TCCAT-3Ј (antisense) to yield a 1567 bp prod- Figure 2 . uct. Polymerase chain reaction (PCR) was performed with a DNA Thermal Cycler (MJ Inc., Watertown, MA, Distribution of ICAM-1 antisense oligonucleotides in USA) using the following program: 94ЊC for one minute, mouse in vivo 60ЊC for one minute, and 72ЊC for two minutes. AmplifiPrevious animal studies have demonstrated that folcations were carried out for 30 cycles. PCR products were lowing systemic administration, phosphorothioate oligoanalyzed by electrophoresis through a 1.0% agarose gel nucleotides are primarily excreted by the kidney and with ethidium bromide (0.5 g/mL). A 1567 bp template that renal tissue levels of the oligonucleotides exceed for the ICAM-1 probe was prepared by PCR of renal that of other organs. Within the kidney, the oligonucleocortex cDNA. The PCR product was isolated from low tides are taken up primarily by proximal tubular cells, melting point agarose and was purified using a Genewith much lower uptake by cells in other segments of clean kit (Cambridge Biosystems, Cambridge, UK).
the nephron [21] . To obtain information about the distribution of ICAM-1 ASON in mice, we injected the FITCNorthern blotting analysis labeled ICAM-1 ASON via tail vein at 10 mg/kg into Total RNA was separated, transferred to a nylon memeither normal mice or mice with UUO operation for 16 brane (Bio-Rad, Hercules, CA, USA), and cross-linked hours. The mice were sacrificed at the 24th hour after by ultraviolet irradiation (UVP, Cambridge, UK). After injection, and the location of the oligonucleotide was being prehybridized, the blots were hybridized with observed in the cryostat sections of the kidney, liver, mouse ICAM-1 cDNA probe labeled with [␣-32 P]dCTP lung, and spleen. In the normal mice, the ICAM-1 ASON using random primed DNA labeling kit (Boehringer localized predominantly to the renal proximal tubular Mannheim, Germany) at 65ЊC for 24 hours. Autoradiogcells. The fluorescein was not detected within the glomerraphy was performed at Ϫ70ЊC using intensifying screens.
uli and the distal tubular cells (Fig. 3) . Much lower levels Statistical analysis of FITC-labeled ICAM-1 ASON were found in the liver, lung, and spleen of the mice. In UUO mice, the distribuThe values of the groups were expressed as means Ϯ tion and level of the oligonucleotide in the obstructed sd. Data were analyzed for statistical significance by kidney were not different from those of the contralateral Student's t-test or Mann-Whitney U-test, and a P value Ͻ0.05 was considered significant. unobstructed kidney. 
Therapeutic effects of ICAM-1 ASON on renal pathological changes in UUO mice
On the seventh day after UUO operation, marked inflammatory cell infiltration, dilated tubules, and extracellular matrix accumulation in the tubulointerstitium were found in the obstructed kidneys of the mice. The number of the inflammatory cells and the degree of the matrix accumulation were alleviated after treatment with tion of the tubules (Fig. 6) . The results of quantitative pathological assay are shown in Table 1 .
Effects of ICAM-1 antisense oligonucleotide on Side effects of ICAM-1 ASON in UUO mice ICAM-1 expression in UUO mice
Phosphorothioate oligonucleotides may result in spleOur previous study demonstrated that there is an innomegaly, lymphoid hyperplasia, and mild liver or kidtense staining of ICAM-1 and a number of Mac-1-ney dysfunction in animals [22] . In the present study, the positive staining cells in the peritubular interstitial space weights of kidney, liver, spleen, the serum chemistry of the obstructed kidney seven days after UUO operaparameters of liver and kidney functions as well as the tion in mice [13] . In the current study, the immunohistourine protein of the mice treated with ICAM-1 ASON logical data showed that the ICAM-1 expression and the were compared with those changes of the control oligonumber of Mac-1-positive cells were markedly denucleotide-treated and normal saline-treated mice. The creased in the renal tubulointerstitium of the obstructed results showed that there were no apparent clinical signs kidney after treatment with ICAM-1 ASON (Fig. 4) .
of toxicity in mice treated with 1 mg/kg ICAM-1 ASON The control oligonucleotide had no effect on ICAM-1 or control oligonucleotide. There were no statistically expression and the number of Mac-1-positive cells in significant changes in the organ weights and chemistry the obstructed kidney of UUO mice. By Northern blot parameters (GPT, BUN, Cr, and urine protein) between analysis, the expression of ICAM-1 mRNA in the renal the mice treated with ICAM-1 ASON, control oligonucortex was also decreased after treatment with ICAM-1 ASON (Fig. 5) .
cleotide, and the normal saline solution. sense therapy. Although the precise mechanism of action has not been Data from previous animal studies on the pharmacoclarified, ASONs offer considerable promise with the dekinetics and tissue distribution of oligonucleotide have velopment of novel molecular therapeutic agents against suggested that the kidney may be an ideal target for diseases including AIDS, cancer, and inflammatory disapplication of ASONs [21, 28, 29] . Following systemic orders [24] . Several investigators have reported the apadministration to both mice and rabbits, radiolabeled plications of ASON to kidney cell lines in vitro. ASON oligonucleotides were excreted primarily in the urine. targeting the mRNA of rat kidney sodium phosphate Tissue levels of oligonucleotide attained in murine kidcotransporter NaPi-2 protein reduced the rate of phosneys were markedly higher than those in all other organs phate uptake into the tubular cell brush border mem- [29, 30] . Similar results are gained in our current study brane vesicles [25] . Glomerular mesangial cells exposed using the FITC-labeled oligonucleotide. to ASONs of proliferating cell nuclear antigen (PCNA)
Recently, researchers have examined the effects of and Ki-67 had decreased levels of PCNA and Ki-67
ASONs in experimental animals in vivo. Spontaneously mRNA and a decreased rate of cell proliferation [26] .
hypertensive rats injected with ASON targeting against Our current study provides evidence that ICAM-1 exeither angiotensinogen or angiotensin II type I receptor pression of the cultured renal TECs is induced by IL-1␤, mRNA had a significant reduction in systemic blood preswhich is interrupted by ICAM-1 ASON.
sure [31] . Haller et al reported the suppression of ICAM-1 Rappaport et al studied the fate of 32 P-labeled oligonuexpression and the attenuation of ischemia/reperfusion cleotides after intravenous injection [27] . The labeled injury by administration of rat ICAM-1 ASON [32] . oligonucleotides were predominantly localized in kidney Other authors demonstrated that the anti-transforming and liver and were detected in the proximal tubular cells within 30 minutes after injection. The electron microgrowth factor-␤ (TGF-␤) ASONs inhibited TGF-␤ ex-pression and glomerular extracellular matrix accumula-UUO mice after treatment with ICAM-1 ASON at the tion in Thy1 glomerulonephritis [33] .
dosage of 1 mg/kg. Ureterally obstructed mice are a cell-mediated model
In conclusion, our studies demonstrate that ICAM-1 for progressive nonimmune renal injury involving macro-ASON has a blocking effect on the infiltration of Mac-1-phages, up-regulated TGF-␤ expression, extracellular positive cells and the extracellular matrix accumulation matrix accumulation, and eventual scarring of the tubuloin the early stages of the injured renal interstitium of interstitial compartment [34] . Up-regulation of ICAM-1 UUO mice. The therapeutic effect of ICAM-1 ASON expression on proximal tubules and the cortical interstimay be owed to its inhibitive effects on ICAM-1 exprestium has been reported in this model. Using immunohission of the renal TECs because the antisense is predomitochemistry and in situ hybridization, Ricardo et al have nantly taken up by renal proximal TECs after intravefound that ICAM-1 and ICAM-1 mRNA transcription nous injection, and the ICAM-1 expression of renal localized to the renal tubules and interstitium of the tubules is inhibited by the ICAM-1 ASON in vitro and renal cortex of obstructed kidney [35] . Our previous in vivo. The treatment with ICAM-1 ASON is safe for study shows that administration of anti-ICAM-1 antithe UUO mice at the therapeutic dosage. body to mice resulted in significant reductions in infiltrating leukocytes and tubular epithelial damage, as as-ACKNOWLEDGMENTS sessed by light microscopy [13] .
